vs
Arena Group Holdings, Inc.（AREN）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Arena Group Holdings, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.4倍（$28.2M vs $19.6M），Arena Group Holdings, Inc.净利率更高（18.9% vs -177.4%，领先196.3%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -22.0%），过去两年Arena Group Holdings, Inc.的营收复合增速更高（-1.2% vs -12.2%）
Arena Group Holdings旗下的Arena Racing Company是英国的赛马休闲企业，2012年由Arena Leisure与Northern Racing合并成立。该公司在英国拥有并运营16家赛马场，占英国赛马赛事总量的39%，同时还在多家赛马场配套经营酒店，在三处场地运营高尔夫球场。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
AREN vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.2M | $19.6M |
| 净利润 | $5.3M | $-34.7M |
| 毛利率 | 43.6% | 48.5% |
| 营业利润率 | 26.6% | -168.5% |
| 净利率 | 18.9% | -177.4% |
| 营收同比 | -22.0% | -11.5% |
| 净利润同比 | -22.5% | -28.8% |
| 每股收益（稀释后） | $0.12 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $28.2M | — | ||
| Q3 25 | $29.8M | $19.6M | ||
| Q2 25 | $45.0M | $21.8M | ||
| Q1 25 | $31.8M | $40.8M | ||
| Q4 24 | $36.2M | — | ||
| Q3 24 | $33.6M | $22.1M | ||
| Q2 24 | $27.2M | $22.5M | ||
| Q1 24 | $28.9M | $45.5M |
| Q4 25 | $5.3M | — | ||
| Q3 25 | $6.9M | $-34.7M | ||
| Q2 25 | $108.6M | $-33.5M | ||
| Q1 25 | $4.0M | $-26.0M | ||
| Q4 24 | $6.9M | — | ||
| Q3 24 | $4.0M | $-26.9M | ||
| Q2 24 | $-8.2M | $-45.7M | ||
| Q1 24 | $-103.4M | $-32.2M |
| Q4 25 | 43.6% | — | ||
| Q3 25 | 50.2% | 48.5% | ||
| Q2 25 | 56.5% | 48.8% | ||
| Q1 25 | 49.3% | 48.4% | ||
| Q4 24 | 52.6% | — | ||
| Q3 24 | 50.6% | 54.9% | ||
| Q2 24 | 39.4% | 46.1% | ||
| Q1 24 | 30.9% | 53.1% |
| Q4 25 | 26.6% | — | ||
| Q3 25 | 31.9% | -168.5% | ||
| Q2 25 | 36.5% | -118.1% | ||
| Q1 25 | 23.1% | -80.8% | ||
| Q4 24 | 28.6% | — | ||
| Q3 24 | 24.0% | -120.9% | ||
| Q2 24 | -9.5% | -134.5% | ||
| Q1 24 | -27.5% | -132.2% |
| Q4 25 | 18.9% | — | ||
| Q3 25 | 23.1% | -177.4% | ||
| Q2 25 | 241.4% | -153.7% | ||
| Q1 25 | 12.6% | -63.8% | ||
| Q4 24 | 19.0% | — | ||
| Q3 24 | 11.8% | -122.0% | ||
| Q2 24 | -30.1% | -203.3% | ||
| Q1 24 | -357.1% | -70.6% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.14 | $-0.09 | ||
| Q2 25 | $2.28 | $-0.09 | ||
| Q1 25 | $0.08 | $-0.07 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.11 | $-0.07 | ||
| Q2 24 | $-0.28 | $-0.12 | ||
| Q1 24 | $-3.91 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.3M | $129.4M |
| 总债务越低越好 | $97.6M | — |
| 股东权益账面价值 | $-4.8M | $399.7M |
| 总资产 | $112.6M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $10.3M | — | ||
| Q3 25 | $12.5M | $129.4M | ||
| Q2 25 | $6.8M | $158.6M | ||
| Q1 25 | $2.9M | $150.9M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $5.8M | $210.6M | ||
| Q2 24 | $6.1M | $269.8M | ||
| Q1 24 | $4.0M | $287.1M |
| Q4 25 | $97.6M | — | ||
| Q3 25 | $110.5M | — | ||
| Q2 25 | $110.5M | — | ||
| Q1 25 | $110.5M | — | ||
| Q4 24 | $110.4M | — | ||
| Q3 24 | $102.4M | $55.2M | ||
| Q2 24 | $102.4M | $55.1M | ||
| Q1 24 | $102.3M | $55.0M |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-10.4M | $399.7M | ||
| Q2 25 | $-17.3M | $424.5M | ||
| Q1 25 | $-126.1M | $454.6M | ||
| Q4 24 | $-130.3M | — | ||
| Q3 24 | $-137.5M | $489.3M | ||
| Q2 24 | $-157.2M | $510.3M | ||
| Q1 24 | $-149.6M | $577.3M |
| Q4 25 | $112.6M | — | ||
| Q3 25 | $121.4M | $539.6M | ||
| Q2 25 | $127.8M | $557.0M | ||
| Q1 25 | $114.6M | $579.6M | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $114.2M | $681.5M | ||
| Q2 24 | $113.4M | $708.7M | ||
| Q1 24 | $120.3M | $777.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.1M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | 2.46× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $13.1M | — | ||
| Q3 25 | $12.2M | $-22.2M | ||
| Q2 25 | $10.3M | $-20.7M | ||
| Q1 25 | $3.7M | $-30.3M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-2.3M | $-27.9M | ||
| Q2 24 | $-3.2M | $-39.0M | ||
| Q1 24 | $-2.0M | $-62.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.4M | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -7.1% | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.1% | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | 2.46× | — | ||
| Q3 25 | 1.77× | — | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | -1.25× | — | ||
| Q3 24 | -0.59× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AREN
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
